Qube Research & Technologies LTD Revance Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

$72.9 Billion
Q4 2024

A detailed history of Qube Research & Technologies LTD transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,328,525 shares of RVNC stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,328,525

Previous 1,891,261 29.75%

Holding current value

$3.41 Million

Previous $4.86 Million 29.75%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	N/A	-562,736 Reduced 29.75%	1,328,525 $3.41 Million
Q3 2024 Nov 14, 2024	BUY	$2.57 - $2.57 $4.86 Million - $4.86 Million	1,891,261 New	1,891,261 $4.86 Million
Q4 2023 Feb 13, 2024	BUY	$5.81 - $11.2 $2.26 Million - $4.36 Million	389,624 Added 341.03%	503,874 $4.43 Million
Q3 2023 Nov 13, 2023	SELL	$11.47 - $25.07 $279,260 - $610,379	-24,347 Reduced 17.57%	114,250 $1.31 Million
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $2.11 Million - $3.22 Million	85,576 Added 161.4%	138,597 $3.51 Million
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $1.63 Million - $3.13 Million	-88,859 Reduced 62.63%	53,021 $1.71 Million
Q4 2022 Feb 14, 2023	BUY	$18.32 - $30.66 $2.07 Million - $3.47 Million	113,211 Added 394.89%	141,880 $2.62 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $410,826 - $816,206	28,669 New	28,669 $774,000
Q3 2021 Nov 12, 2021	SELL	$25.78 - $33.21 $604,154 - $778,276	-23,435 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$26.8 - $31.84 $628,058 - $746,170	23,435 New	23,435 $695,000
Q4 2020 Feb 16, 2021	SELL	$23.41 - $28.34 $336,003 - $406,764	-14,353 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$23.23 - $34.3 $28,712 - $42,394	1,236 Added 9.42%	14,353 $361,000
Q2 2020 Aug 14, 2020	BUY	$12.6 - $26.55 $165,274 - $348,256	13,117 New	13,117 $320,000

Others Institutions Holding RVNC

# of Institutions

208

Shares Held

80.9M

Call Options Held

2.26M

Put Options Held

5.48M

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Revance Therapeutics, Inc. Transaction History